Article
Molecular Epidemiology of EGFR Mutations in Asian Patients with Advanced Non-Small-Cell Lung Cancer of Adenocarcinoma Histology - Mainland China Subset Analysis of the PIONEER study.
PloS one - 1 Jan 2015
Shi Yuankai, Li Junling, Zhang Shucai, Wang Mengzhao, Yang Shujun, Li Ning, Wu Gang, Liu Wei, Liao Guoqing, Cai Kaican, Chen Liang'an, Zheng Meizhen, Yu Ping, Wang Xiuwen, Liu Yunpeng, Guo Qisen, Nie Ligong, Liu Jiwei, Han Xiaohong
Abstract excerpt
Epidermal growth factor receptor (EGFR) mutations are the strongest response predictors to EGFR tyrosine kinase inhibitors (TKI) therapy, but knowledge of the EGFR mutation frequency on lung adenocarcinoma is still limited to retrospective studies. The PIONEER study (NCT01185314) is a prospective molecular epidemiology study in Asian patients with newly diagnosed advanced lung adenocarcinoma, aiming to...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.